Tender for the supply of "Kyprolis" via Negotiated Procedure without Prior Publication of a Contract Notice, Ref. No.: F.Y.Y.13.25.02.08.195.1, DDHDDPD.SPYY 167/2024 (OAY)

This tender concerns the procurement of the pharmaceutical product "Kyprolis". The procedure being followed is a Negotiated Procedure without Prior Publication of a Contract Notice, as stipulated by the relevant legislation governing public procurement procedures. Specifically, this is in accordance with Article 29 (2) (b) (ii) of the Law on the Regulation of Public Procurement Procedures and Related Matters, Law 73(I) of 2016. The reference number for this procurement is F.Y.Y.13.25.02.08.195.1, with the specific tender identifier DDHDDPD.SPYY 167/2024 (OAY). The objective is to secure a supply of "Kyprolis", which is a critical medication, likely for use within the public healthcare system. The use of a negotiated procedure without prior publication suggests that specific circumstances, such as urgency or the exclusive nature of the product, may have necessitated this approach, allowing direct negotiation with potential suppliers. Further details regarding the specific quantities, delivery timelines, and eligibility criteria for participating entities would typically be provided in the full tender documentation. This procurement falls under the pharmaceutical sector and aims to ensure the availability of essential medicines for patients.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in CY, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.